Fisher & Paykel - Public Comps and Valuation Multiples

Fisher & Paykel Overview

About Fisher & Paykel

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.

Founded

1969

HQ

Employees

7.5K+

Website

fphcare.com

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $1.3B

LTM EBITDA $419M

EV

$13.0B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Fisher & Paykel Financials

As of December 2025, Fisher & Paykel reported last 12-month revenue of $1.3B and EBITDA of $419M.

In the same period, Fisher & Paykel generated $811M in LTM gross profit and $249M in net income.

See Fisher & Paykel valuation multiples based on analyst estimates

Fisher & Paykel P&L

In the most recent fiscal year, Fisher & Paykel reported revenue of $736M and EBITDA of $376M.

Fisher & Paykel expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Fisher & Paykel valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	$1.3B	XXX	$736M	XXX	XXX	XXX
Gross Profit	$811M	XXX	$305M	XXX	XXX	XXX
Gross Margin	64%	XXX	41%	XXX	XXX	XXX
EBITDA	$419M	XXX	$376M	XXX	XXX	XXX
EBITDA Margin	33%	XXX	51%	XXX	XXX	XXX
EBIT	$335M	XXX	-$213M	XXX	XXX	XXX
EBIT Margin	26%	XXX	-29%	XXX	XXX	XXX
Net Profit	$249M	XXX	$217M	XXX	XXX	XXX
Net Margin	20%	XXX	29%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Fisher & Paykel including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $1.3B. EBITDA for the last twelve months was $419M. In the most recent fiscal year, Fisher & Paykel achieved $736M in revenue and $376M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	$1.3B	Analyst estimates available to subscribers	$736M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$811M	Analyst estimates available to subscribers	$305M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	64.1% gross margin	Analyst estimates available to subscribers	41.4% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$419M	Analyst estimates available to subscribers	$376M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	33.1% EBITDA margin	Analyst estimates available to subscribers	51.1% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$335M	Analyst estimates available to subscribers	-$213M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	26.5% EBIT margin	Analyst estimates available to subscribers	-29.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$249M	Analyst estimates available to subscribers	$217M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	19.7% net profit margin	Analyst estimates available to subscribers	29.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Fisher & Paykel

This financial data table provides comprehensive performance metrics for Fisher & Paykel, a company based in New Zealand. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Fisher & Paykel generated $1.3B in revenue over the last twelve months.
The company achieved $419M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $811M.
Net income over the last twelve months reached $249M.

Fiscal Year Performance

In the most recent fiscal year, Fisher & Paykel reported $736M in total revenue.
Fiscal year EBITDA was $376M.
The company maintained a gross profit margin of 41.4% in the most recent fiscal year.
EBITDA margin for the fiscal year was 51.1%.
Net profit margin reached 29.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Fisher & Paykel. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Fisher & Paykel Stock Performance

Fisher & Paykel has current market cap of NZD 22.7B (or $13.0B), and EV of NZD 22.5B (or $13.0B).

Market Cap Evolution

Fisher & Paykel Stock Data

As of January 19, 2026, Fisher & Paykel's stock price is NZD 39 (or $22).

See Fisher & Paykel trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$13.0B	$13.0B	XXX	XXX	XXX	XXX	$0.42

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Fisher & Paykel Valuation Multiples

Fisher & Paykel's trades at 11.2x EV/Revenue multiple, and 30.9x EV/EBITDA.

See valuation multiples for Fisher & Paykel and 15K+ public comps

Fisher & Paykel Financial Valuation Multiples

As of January 19, 2026, Fisher & Paykel has market cap of $13.0B and EV of $13.0B.

Equity research analysts estimate Fisher & Paykel's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Fisher & Paykel has a P/E ratio of 52.3x.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$13.0B	XXX	$13.0B	XXX	XXX	XXX
EV (current)	$13.0B	XXX	$13.0B	XXX	XXX	XXX
EV/Revenue	10.2x	XXX	11.2x	XXX	XXX	XXX
EV/EBITDA	30.9x	XXX	30.9x	XXX	XXX	XXX
EV/EBIT	38.7x	XXX	62.3x	XXX	XXX	XXX
EV/Gross Profit	16.0x	XXX	n/a	XXX	XXX	XXX
P/E	52.3x	XXX	52.4x	XXX	XXX	XXX
EV/FCF	57.9x	XXX	58.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Fisher & Paykel Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Fisher & Paykel Margins & Growth Rates

Fisher & Paykel's last 12 month revenue growth is 11%

Fisher & Paykel's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Fisher & Paykel's rule of 40 is 53% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Fisher & Paykel's rule of X is 62% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Fisher & Paykel and other 15K+ public comps

Fisher & Paykel Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	11%	XXX	16%	XXX	XXX	XXX
EBITDA Margin	33%	XXX	36%	XXX	XXX	XXX
EBITDA Growth	15%	XXX	20%	XXX	XXX	XXX
Rule of 40	53%	XXX	48%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	62%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	42%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	18%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	70%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial